Arvinas Inc
NASDAQ:ARVN
Arvinas Inc
NASDAQ:ARVN
Price:
10.6
USD
4.13%
Market Closed
Market Cap:
$678m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Arvinas Inc
NASDAQ:ARVN
|
US |
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
SA |
|
Portmeirion Group PLC
LSE:PMP
|
UK |
|
Konecranes Abp
OTC:KNCRF
|
FI |
|
Fukuyama Transporting Co Ltd
TSE:9075
|
JP |
Balance Sheet
Balance Sheet Decomposition
Arvinas Inc
Arvinas Inc
Balance Sheet Decomposition is not available for
Arvinas Inc
Arvinas Inc
Balance Sheet
Arvinas Inc
Arvinas Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
5
|
31
|
3
|
9
|
588
|
108
|
81
|
312
|
101
|
143
|
|
| Cash Equivalents |
5
|
31
|
3
|
9
|
588
|
108
|
81
|
312
|
101
|
143
|
|
| Short-Term Investments |
31
|
8
|
185
|
272
|
100
|
1 394
|
1 124
|
949
|
939
|
543
|
|
| Total Receivables |
1
|
26
|
5
|
6
|
8
|
26
|
8
|
7
|
14
|
6
|
|
| Accounts Receivables |
0
|
25
|
3
|
0
|
1
|
15
|
1
|
0
|
6
|
1
|
|
| Other Receivables |
1
|
1
|
2
|
6
|
7
|
11
|
7
|
7
|
8
|
5
|
|
| Other Current Assets |
0
|
0
|
3
|
4
|
6
|
24
|
27
|
12
|
14
|
9
|
|
| Total Current Assets |
37
|
66
|
196
|
291
|
703
|
1 553
|
1 240
|
1 280
|
1 067
|
701
|
|
| PP&E Net |
1
|
1
|
4
|
11
|
14
|
17
|
18
|
14
|
16
|
13
|
|
| PP&E Gross |
1
|
1
|
4
|
11
|
14
|
17
|
18
|
14
|
16
|
13
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
3
|
6
|
11
|
17
|
21
|
26
|
28
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
13
|
11
|
10
|
8
|
4
|
|
| Total Assets |
38
N/A
|
67
+76%
|
199
+198%
|
302
+51%
|
717
+138%
|
1 582
+120%
|
1 269
-20%
|
1 305
+3%
|
1 091
-16%
|
718
-34%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
1
|
3
|
5
|
7
|
31
|
6
|
110
|
13
|
94
|
|
| Accrued Liabilities |
2
|
4
|
4
|
8
|
20
|
24
|
61
|
76
|
57
|
42
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
7
|
14
|
16
|
20
|
22
|
206
|
229
|
164
|
159
|
76
|
|
| Total Current Liabilities |
10
|
18
|
23
|
33
|
49
|
262
|
295
|
257
|
230
|
143
|
|
| Long-Term Debt |
0
|
0
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
|
| Other Liabilities |
4
|
49
|
38
|
40
|
24
|
537
|
408
|
387
|
299
|
141
|
|
| Total Liabilities |
14
N/A
|
67
+379%
|
63
-6%
|
75
+20%
|
75
+0%
|
800
+965%
|
704
-12%
|
645
-8%
|
530
-18%
|
284
-46%
|
|
| Equity | |||||||||||
| Common Stock |
58
|
63
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
34
|
62
|
302
|
373
|
492
|
683
|
965
|
1 333
|
1 532
|
1 612
|
|
| Additional Paid In Capital |
0
|
0
|
439
|
599
|
1 134
|
1 469
|
1 549
|
1 996
|
2 092
|
2 137
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
92
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
5
|
19
|
3
|
1
|
1
|
|
| Total Equity |
24
N/A
|
0
-99%
|
137
+68 250%
|
227
+66%
|
642
+183%
|
782
+22%
|
565
-28%
|
660
+17%
|
562
-15%
|
434
-23%
|
|
| Total Liabilities & Equity |
38
N/A
|
67
+76%
|
199
+198%
|
302
+51%
|
717
+138%
|
1 582
+120%
|
1 269
-20%
|
1 305
+3%
|
1 091
-16%
|
718
-34%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
31
|
31
|
31
|
39
|
49
|
53
|
53
|
68
|
69
|
64
|
|
Switch to:
Switch to:
See Also
Discover More
